Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company’s product is Portable Neuromodulation Stimulator, a non- implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
Metrics to compare | HSDT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHSDTPeersSector | |
---|---|---|---|---|
P/E Ratio | −0.4x | −4.2x | −0.5x | |
PEG Ratio | - | −0.02 | 0.00 | |
Price/Book | 3.7x | 1.5x | 2.6x | |
Price / LTM Sales | 10.8x | 3.8x | 3.3x | |
Upside (Analyst Target) | - | 78.6% | 42.4% | |
Fair Value Upside | Unlock | 12.2% | 7.2% | Unlock |